Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
ISSN: 2155-9899
Geraldine Cambridge
Founding director, seed investor and non-executive director in Cambridge gene editing company
Dr Rodgers joined Cambridge University in 1994 as business manager for Professor Chris Lowe at the Institute of Biotechnology and later moved to the technology transfer office.She moved to the Challenge Fund in 2000 as investment manager and stepped up to head the Cambridge Enterprise Seed Funds in September 2007 with responsibility for managing the entire Cambridge Enterprise Group portfolio. She was also a former lecturer on the university's Masters of Bioscience Enterprise programme.
Research interest in Rituximab Rituxan; Ig: Immunoglobulin; DMARD: Disease Modifying Anti-Rheumatic Drug, Hypogammaglobulinaemia; DAS28; Infections